Dr. Lal PathLabs Q2 FY25: Steady Growth and a Landmark Reward for Shareholders
Dr. Lal PathLabs, a leading name in the diagnostic services sector, has announced its financial results for the second quarter of Fiscal Year 2025, demonstrating consistent and profitable growth. Alongside the solid earnings, the company’s Board of Directors has made a landmark decision that is set to directly reward its shareholders, signaling strong confidence in … Read more